cytidine diphosphate choline has been researched along with dizocilpine maleate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisher, M; Li, F; Locke, KW; Onal, MZ; Sandage, BW; Tatlisumak, T | 1 |
Grieb, P; Rejdak, K; Rejdak, R; Sieklucka-Dziuba, M; Stelmasiak, Z | 1 |
Cavun, S; Savci, V; Ulus, IH | 1 |
Deutsch, SI; Gaskins, BL; Long, KD; Mastropaolo, J; Rosse, RB; Schooler, NR; Schwartz, BL | 1 |
4 other study(ies) available for cytidine diphosphate choline and dizocilpine maleate
Article | Year |
---|---|
Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats.
Topics: Animals; Cerebral Infarction; Cytidine Diphosphate Choline; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Survival Analysis | 1997 |
The effects of citicoline and/or MK-801 on survival, neurological and behavioral outcome of mice exposed to transient hyperglycemia and oligemic hypoxia.
Topics: Animals; Behavior, Animal; Brain Ischemia; Cytidine Diphosphate Choline; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hyperglycemia; Hypoxia; Male; Mice; Motor Activity; Nervous System | 2001 |
Centrally injected CDP-choline increases plasma vasopressin levels by central cholinergic activation.
Topics: Animals; Atropine; Cholinergic Agents; Cytidine; Cytidine Diphosphate Choline; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hemicholinium 3; Injections, Intraventricular; Male; Mecamylamine; Muscarinic Antagonists; Nicotinic Antagonists; Nootropic Agents; Parasympathetic Nervous System; Rats; Rats, Wistar; Receptors, Presynaptic; Stimulation, Chemical; Synapses; Vasopressins | 2004 |
Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cholinesterase Inhibitors; Cytidine Diphosphate Choline; Disease Models, Animal; Dizocilpine Maleate; Drug Interactions; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Galantamine; Male; Mice; Nootropic Agents; Schizophrenia | 2008 |